Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemia

Alessandra Ferrajoli, Michael J. Keating, Susan O'Brien, Jorge Cortes, Deborah A. Thomas

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences